glp 1 seizures Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety Could GLP-1 Drugs Lower Epilepsy

doi: 10.1016/j.neulet.2015.12.007 [DOI] [PubMed] [Google Scholar] 196

Cholelithiasis occurred in 4% of the semaglutide group, versus no incidence in the placebo group [14]

P = .03)

The future of GLP-1 RAs lies in their potential to address a wider array of metabolic disorders, supported by ongoing research and innovation (43)(47).GLP-1 receptor agonists, when integrated into comprehensive treatment plans, serve as tools in improving the lives of patients with T2DM and obesity

Monfredi O, Dobrzynski H, Mondal T, Boyett MR, Morris GM

If the taste becomes strong, persistent, or is accompanied by ongoing nausea, vomiting, or discomfort, it is important to seek clinical advice